SurveyThe CC chemokine CCL20 and its receptor CCR6
Introduction
Chemokines constitute a family of structurally related chemotactic cytokines that direct the migration of leukocytes throughout the body, both under physiological and inflammatory conditions [1]. Furthermore, they are involved in processes like angiogenesis, morphogenesis, autoimmunity, tumor growth and metastasis. Generally, chemokines exert their various biological functions by activating 7-transmembrane-domain G protein-coupled receptors on their target cells [2]. According to the presence and the relative position of the NH2-terminal Cys residues, chemokines are structurally grouped into the CC, CXC, CX3C and C chemokines. A first generation of chemokines was mainly discovered on the basis of their chemotactic properties. Most of them are believed to play a central role in the recruitment of the soldiers of the immune system at inflammatory sites upon strong induction in a large spectrum of cell types. Since 1996, a second generation of chemokines emerged largely on account of developments in bioinformatics and expressed sequence tag (EST) databases. Most of these chemokines are expressed constitutively but selectively in some specific cell types and are assumed to orchestrate the homeostatic trafficking of leukocytes and the organization of lymphoid tissues [3]. However, some second-generation chemokines, such as CCL20, are expected to act both as constitutive/homeostatic and inducible/inflammatory chemokines, depending on the conditions [4].
Section snippets
Discovery of CCL20
Human CCL20 was simultaneously reported by three different groups as the first chemokine discovered through bioinformatics-based searches of DNA databases and automated sequencing techniques. Screening the public GenBank EST database with amino acid and nucleotide sequences of various known CC chemokines, Hieshima et al. identified five partial, overlapping cDNA sequences (three from pancreatic islets, one from fetal lung and one from HepG2 hepatocytic cells) likely to encode a novel human CC
Structure of CCL20 gene
In contrast to the first-generation CC chemokines genes, all clustered at chromosome 17q11.2, the human CCL20 gene (SCYA20) was mapped to chromosome 2q33-37 [5], [12]. Since CCL20 is only distantly related to other CC chemokines, its gene may have been generated before amplification of the CC chemokines on chromosome 17. Intron/exon junctions of the CC chemokine subfamily members are normally highly conserved, with the majority containing three exons and two introns. However, the CCL20 gene,
Structure of CCL20 protein
The full-length CCL20 cDNA contains an open reading frame (ORF) encoding a 96-amino acid precursor protein. The NH2-terminus of the corresponding amino acid sequence is highly hydrophobic and is consistent with a typical signal sequence. The cleavage site has been predicted to be located between the two Ala residues at position 26 and 27 of the precursor protein, theoretically giving rise to a mature protein of 70 amino acids, CCL20(1-70) [5], [6]. However, the pancreas-derived ESTs that were
Discovery of CCR6, the selective receptor for CCL20
In 1996, Zaballos et al. discovered through a degenerate primer strategy a putative chemokine receptor, CKR-L3, but failed to identify a functional ligand for this lymphocyte-specific receptor [26]. Liao et al. cloned the genomic sequence of this orphan receptor, alternatively named STRL22 [27], from tumor-infiltrating lymphocytes (TIL) and the same receptor was also deposited as DRY6 and GPR-CY4 in the GenBank database. Baba et al. were the first to identify CCL20 as a highly selective and
CCR6 expression and spectrum of in vitro biological activities of CCL20
With the availability of commercial Northern blot filters covering different human tissues, CCR6 was immediately demonstrated to be constitutively expressed in both lymphoid and non-lymphoid organs: predominantly in spleen, lymph nodes, appendix and pancreas, and to a lesser degree in peripheral blood leukocytes, thymus, small intestine, fetal liver and testis [26], [27], [28], [30]. Furthermore, CCR6 transcripts were originally reported in lymphocytes and in DC, but not in monocytes [21], [26]
CCL20 expression
Despite the designation LARC, constitutive expression of CCL20 was originally demonstrated in several tissues in addition to liver (mainly in mucosa-associated and lymphoid tissues) with the use of commercially available multi-tissue Northern blot filters (Table 2). Simultaneously, the inducibility of CCL20 was evidenced in different cell types, primarily in monocytic cells (Table 3). However, the spectrum of cellular sources, inducers as well as CCL20-expressing tissues broadened rapidly
Potential role of CCL20 and CCR6 in homeostasis and pathology
The findings on CCL20 expression in a broad spectrum of cell and tissue types and on the variety of CCL20-inducing agents, suggest that CCL20 and CCR6 are involved in both normal and pathological processes (Table 4), especially at epithelial surfaces. Here, the potential role of CCL20 and CCR6 in skin and mucosal immunity, in cancer and in rheumatoid arthritis will be highlighted.
Acknowledgements
This work was supported by the Fund for Scientific Research of Flanders (FWO-Vlaanderen), the Concerted Research Actions of the Regional Government of Flanders, the InterUniversity Attraction Pole Initiative of the Belgian Federal Government and the Quality of Life Program of the European Community. S.S. holds a fellowship from the FWO-Vlaanderen. We thank Prof. J. Balzarini (K.U. Leuven, Belgium), Prof. A. Billiau (K.U. Leuven, Belgium), Prof. P. Hoet (K.U. Leuven, Belgium), Prof. G. Laureys
References (135)
- et al.
Chemokines in immunity
Adv. Immunol.
(2001) The chemokine system: redundancy for robust outputs
Immunol. Today
(1999)- et al.
Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2
J. Biol. Chem.
(1997) - et al.
Cloning and characterization of Exodus, a novel β-chemokine
Blood
(1997) - et al.
Chemokines: a new classification system and their role in immunity
Immunity
(2000) - et al.
Molecular cloning, functional characterization and mRNA expression analysis of the murine chemokine receptor CCR6 and its specific ligand MIP-3α
FEBS Lett.
(1998) - et al.
A novel rat CC chemokine, identified by targeted differential display, is upregulated in brain inflammation
J. Neuroimmunol.
(1998) - et al.
Molecular cloning and sequencing of 25 different rhesus macaque chemokine cDNAs reveals evolutionary conservation among C, CC, CXC, and CX3C families of chemokines
Cytokine
(2002) - et al.
Genomic organization of the CC chemokine MIP-3α/CCL20/LARC/Exodus/SCYA20, showing gene structure, splice variants, and chromosome localization
Genomics
(2001) - et al.
Human macrophage inflammatory protein-3α/CCL20/LARC/Exodus/SCYA20 is transcriptionally upregulated by tumor necrosis factor-α via a non-standard NF-κB site
FEBS Lett.
(2001)